Physiology

Professor, Physiology, Professor, Evelyn F Mcknight Brain Institute, Professor, Speech/Language and Hearing, Professor, BIO5 Institute
Professor, Physiology, Professor, Cellular and Molecular Medicine, Professor, Physiological Sciences - GIDP, Associate Research Scientist, Respiratory Sciences, Professor, BIO5 Institute
Professor, Physiology, Professor, Medicine, Professor, Biomedical Engineering, Professor, Physiological Sciences - GIDP, Associate Professor, Pharmacology, Professor, BIO5 Institute
Department Head, Physiology, Professor, Physiology, Professor, Ophthalmology, Member of the Graduate Faculty, Professor, BIO5 Institute
Associate Department Head, Research - Physiology, Member of the Graduate Faculty, Professor, BIO5 Institute, Professor, Biomedical Engineering, Professor, Neuroscience - GIDP, Professor, Physiological Sciences - GIDP, Professor, Physiology

My laboratory studies how the retina takes visual information about the world and transmits it to the brain. We are trying to understand how this signaling responds to changing amounts of background light and becomes dysfunctional in diabetes.

Professor, Physiology, Assistant Professor, Evelyn F Mcknight Brain Institute, Assistant Professor, Neurobiology, Associate Professor, Neurology, Associate Professor, Physiological Sciences - GIDP, Member of the Graduate Faculty, Assistant Professor, BIO5 Institute

The broad goal of Katalin Gothard's research is to understand the neural basis of emotion and social behavior. Her lab work reveals the real-time dynamic interactions in multiple systems implicated in emotion regulation and the mechanisms by which emotional responses produce immediate behavioral effects.

Professor, Physiology, Professor, Evelyn F Mcknight Brain Institute, Professor, Psychology, Professor, Physiological Sciences - GIDP, Professor, BIO5 Institute

Our lab is focused on the development of novel peptides to inhibit this inflammatory cascade and improve brain blood flow. These peptides are designed to significantly improve serum half-life and penetrate the blood-brain-barrier. These peptides act to inhibit the inflammatory pathways at both the level of brain blood vessels and the brain itself.

Professor, Physiology, Associate Professor, Pharmacology, Professor, Biomedical Engineering, Professor, Physiological Sciences - GIDP, Director, Aribi Institute, Associate Director, Shared Resources, Professor, BIO5 Institute

Precise diagnosis and treatment of disease requires an ability to target agents to specific tissues and cell types within those tissues. We are developing agents that exhibit cell type specificity for these purposes.

Assistant Professor, Physiology , Assistant Professor, Surgery , Member of the General Faculty, Member of the Graduate Faculty

Dr. Pires is an Assistant Professor and Principal Investigator in the Department of Physiology, University of Arizona College of Medicine Tucson. Dr. Pires received his Ph.D. in Pharmacology and Toxicology at Michigan State University and completed his training as a Postdoctoral Fellow at the University of Nevada, Reno School of Medicine. Throughout his career Dr. Pires has published numerous research articles on the impact of chronic cardiovascular diseases in development of cerebral vascular disorders, such as ischemic strokes, as well as mechanisms regulating cerebral vascular function. In his laboratory, Dr. Pires' research focuses on the vascular component underlying neurodegenerative diseases, such as cerebral amyloid angiopathy and Alzheimer's diseases, as well as the brain waste clearance system, the glymphatic / cervical lymphatic system.

Professor, Physiology, Professor, Biochemistry/Molecular Biophysics, Professor, Physiological Sciences - GIDP, Investigator, Center for Toxicology, Professor, BIO5 Institute

The kidney plays a critical role in clearing the body of potentially harmful compounds, including many commonly prescribed drugs. Unfortunately, this also sets the kidney up as a site where multiple drugs can interact in unwanted ways. We study the cellular transport processes responsible for renal drug clearance with the intent of developing predictive models that can assist clinicians, drug companies, and the Food & Drug Administration in their efforts to increase patient safety.